Home » All » Stock Forecast » Radiopharm Theranostics Limited American Depositary Shares Forecast

Radiopharm Theranostics Limited American Depositary Shares Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -2.82%Market Cap $59.37M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$4.71 ▲ +1.15%	Yesterday	$4.63 ▼ -0.48%	Tomorrow's Radiopharm Theranostics Limited American Depositary Shares (RADX) setup is anchored to $4.66 and targets $4.71 (+1.15%). The near-term read is upside; watch $4.79 / $4.52 because daily realized volatility is about 5.93%.
Tomorrow's Radiopharm Theranostics Limited American Depositary Shares (RADX) setup is anchored to $4.66 and targets $4.71 (+1.15%). The near-term read is upside; watch $4.79 / $4.52 because daily realized volatility is about 5.93%.
Week	$4.82 ▲ +3.58%	Last Week	$4.59 ▼ -1.50%	The 7-day Radiopharm Theranostics Limited American Depositary Shares model moves from $4.59 to $4.82 (+3.58%). It gives upside momentum context for this stock, so breaks around $4.79 / $4.52 matter more than a single tick.
The 7-day Radiopharm Theranostics Limited American Depositary Shares model moves from $4.59 to $4.82 (+3.58%). It gives upside momentum context for this stock, so breaks around $4.79 / $4.52 matter more than a single tick.
Month	$5.01 ▲ +7.61%	Last Month	$4.51 ▼ -3.20%	The 1-month Radiopharm Theranostics Limited American Depositary Shares target is $5.01 (+7.61%), compared with the live reference near $4.66. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Radiopharm Theranostics Limited American Depositary Shares target is $5.01 (+7.61%), compared with the live reference near $4.66. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$5.29 ▲ +13.67%	Last Year	$4.39 ▼ -5.74%	The 1-year Radiopharm Theranostics Limited American Depositary Shares scenario points to $5.29 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Radiopharm Theranostics Limited American Depositary Shares scenario points to $5.29 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$5.95 ▲ +27.86%	5 Years Ago	$4.11 ▼ -11.70%	The 5-year Radiopharm Theranostics Limited American Depositary Shares view is $5.95 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Radiopharm Theranostics Limited American Depositary Shares view is $5.95 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$4.71▲ +1.15%

Yesterday$4.63▼ -0.48%

Tomorrow's Radiopharm Theranostics Limited American Depositary Shares (RADX) setup is anchored to $4.66 and targets $4.71 (+1.15%). The near-term read is upside; watch $4.79 / $4.52 because daily realized volatility is about 5.93%.

Week$4.82▲ +3.58%

Last Week$4.59▼ -1.50%

The 7-day Radiopharm Theranostics Limited American Depositary Shares model moves from $4.59 to $4.82 (+3.58%). It gives upside momentum context for this stock, so breaks around $4.79 / $4.52 matter more than a single tick.

Month$5.01▲ +7.61%

Last Month$4.51▼ -3.20%

The 1-month Radiopharm Theranostics Limited American Depositary Shares target is $5.01 (+7.61%), compared with the live reference near $4.66. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$5.29▲ +13.67%

Last Year$4.39▼ -5.74%

The 1-year Radiopharm Theranostics Limited American Depositary Shares scenario points to $5.29 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$5.95▲ +27.86%

5 Years Ago$4.11▼ -11.70%

The 5-year Radiopharm Theranostics Limited American Depositary Shares view is $5.95 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$4.66	Mid
Daily Change	-2.82%	Below
Volatility Cap	20.0%	Mid
Confidence	63%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$4.66

Daily Change-2.82%

Market Cap$59.37M

Sourcenasdaq-screener

Current	$4.66	Daily Change	-2.82%
Market Cap	$59.37M	Source	nasdaq-screener

Support & Resistance Levels

$4.52Support 1

$4.66Current

$4.79Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$4.66Live reference price

Used as the anchor for generated forecast calculations.

Next Month$5.01Model projection+7.61%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

63%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

63%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in RADX today

Bullish Scenario

$4.89

+5.00% from current

Target Price$4.89

ScenarioUpside momentum

Probability55%

Base Scenario

$5.01

+7.61%

Target Price$5.01

ScenarioCapped drift

Probability63%

Bearish Scenario

$4.42

-5.00% from current

Target Price$4.42

ScenarioVolatility drawdown

Probability37%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 66/100

24H drift+1.15%

7D drift+3.58%

30D drift+7.61%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 64/100

1M outlook+7.61%

1Y outlook+13.67%

5Y outlook+27.86%

Frequently Asked Questions

Q What is the Radiopharm Theranostics Limited American Depositary Shares (RADX) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Radiopharm Theranostics Limited American Depositary Shares is projected near $4.71 versus the current reference around $4.66. That implies a modeled move of +1.15% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for RADX?

The weekly Radiopharm Theranostics Limited American Depositary Shares model points to $4.82, which maps to an expected drift of +3.58% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Radiopharm Theranostics Limited American Depositary Shares 1-month and 1-year targets?

The Radiopharm Theranostics Limited American Depositary Shares 1-month target is $5.01 (+7.61%), while the 1-year target is $5.29 (+13.67%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Radiopharm Theranostics Limited American Depositary Shares 5-year scenario differ from short-term rows?

The Radiopharm Theranostics Limited American Depositary Shares long-horizon scenario sits near $5.95 with a modeled change of +27.86%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are RADX support and resistance zones right now?

For Radiopharm Theranostics Limited American Depositary Shares, nearest resistance is around $4.52, while nearest support is around $4.79. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Radiopharm Theranostics Limited American Depositary Shares market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.